<DOC>
	<DOCNO>NCT00642174</DOCNO>
	<brief_summary>This trial design phase 2 randomize , double-blind double dummy , active comparator control , two-period two-arm crossover study enroll 40 patient across multiple center . The study compare platelet function follow prasugrel load dose 1 week prasugrel maintenance therapy high-dose clopidogrel load dose 1 week high-dose clopidogrel maintenance therapy patient drug treat type 2 diabetes mellitus coronary artery disease . Various assay platelet function use study . Platelet function study use follow assay : Accumetrics VerifyNowTM P2Y12 , Light Transmittance Aggregometry ( LTA ) , Vasodilator-associated stimulate phosphoprotein ( VASP ) , Thromboelastography ( TEG ) -platelet mapping .</brief_summary>
	<brief_title>Third Optimizing Anti-Platelet Therapy Diabetes MellitUS ( OPTIMUS-3 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Prasugrel Hydrochloride</mesh_term>
	<criteria>Type 2 Diabetes Mellitus oral parenteral hypoglycemic therapy least 1 month . History Coronary Artery Disease without type vascular disease ( peripheral vascular disease ) . Taking Aspirin 75325 mg/day least 1 week prior randomization . Between age 1874 year old . If woman child bear age , must pregnant must agree use reliable method birth control duration study . Thienopyridine therapy within 30 day define need thienopyridine treatment . Coronary Artery Bypass Graft ( CABG ) Percutaneous Coronary Intervention ( PCI ) stent place within 30 day . Planned coronary revascularization Hemoglobin A1c ( HbA1c ) &gt; equal 10 mg/dL within last 3 month . Received fibrolytic therapy &lt; 24 hour prior randomization . Received nonfibrinspecific fibrinolytic therapy &lt; 48 hour prior randomization . At risk bleeding . History ischemic stroke , transient ischemic attack ( TIA ) , intercranial neoplasm , arteriovenous malformation , aneurysm . Body weight &lt; 60 kilogram ( kg ) . International Normalized Ratio ( INR ) &gt; 1.5 , platelet count &lt; 100,000/mm3 , anemia ( hemoglobin &lt; 10 gm/dL ) within 1 week study entry . Are receive receive oral anticoagulation antiplatelet treatment therapy . Are treated daily nonsteroidal antiinflammatory drug ( NSAIDS ) . Are pregnant , breastfeed plan become pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>